Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial.
J Infect Dis. 2024 Jul 25;230(1):e4-e16. doi: 10.1093/infdis/jiad508.
J Infect Dis. 2024.
PMID: 39052718
Free PMC article.
Clinical Trial.
North American pitseed goosefoot (Chenopodium berlandieri) is a genetic resource to improve Andean quinoa (C. quinoa).
Maughan PJ, Jarvis DE, de la Cruz-Torres E, Jaggi KE, Warner HC, Marcheschi AK, Bertero HD, Gomez-Pando L, Fuentes F, Mayta-Anco ME, Curti R, Rey E, Tester M, Jellen EN.
Maughan PJ, et al. Among authors: marcheschi ak.
Sci Rep. 2024 May 29;14(1):12345. doi: 10.1038/s41598-024-63106-8.
Sci Rep. 2024.
PMID: 38811833
Free PMC article.
Item in Clipboard
Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial.
Bennett C, Woo W, Bloch M, Cheung K, Griffin P, Mohan R, Deshmukh S, Arya M, Cumming O, Neville AM, McCallum Pardey TG, Plested JS, Cloney-Clark S, Zhu M, Kalkeri R, Patel N, Marcheschi A, Swan J, Smith G, Cho I, Glenn GM, Walker R, Mallory RM; Novavax 2019nCoV-311 Study Group.
Bennett C, et al. Among authors: marcheschi a.
Lancet Infect Dis. 2024 Jun;24(6):581-593. doi: 10.1016/S1473-3099(24)00077-X. Epub 2024 Mar 6.
Lancet Infect Dis. 2024.
PMID: 38460525
Clinical Trial.
Item in Clipboard
Predictive Modeling of COVID-19 Intensive Care Unit Patient Flows and Nursing Complexity: A Monte Carlo Simulation Study.
Simoncini E, Jarry A, Moussion A, Marcheschi A, Giordanino P, Lusenti C, Bruder N, Velly L, Boussen S; GRAM+ (Groupe de Recherche en Réanimation et Anesthésie de Marseille Pluridisciplinaire).
Simoncini E, et al. Among authors: marcheschi a.
Comput Inform Nurs. 2024 Jun 1;42(6):457-462. doi: 10.1097/CIN.0000000000001100.
Comput Inform Nurs. 2024.
PMID: 38252546
Item in Clipboard
Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373.
Alves K, Plested JS, Galbiati S, Chau G, Cloney-Clark S, Zhu M, Kalkeri R, Patel N, Smith K, Marcheschi A, Pfeiffer S, McFall H, Smith G, Glenn GM, Dubovsky F, Mallory RM; Novavax 2019nCoV-101 Study Group.
Alves K, et al. Among authors: marcheschi a.
Vaccine. 2023 Jun 29;41(29):4280-4286. doi: 10.1016/j.vaccine.2023.05.051. Epub 2023 Jun 2.
Vaccine. 2023.
PMID: 37271706
Free PMC article.
Clinical Trial.
Item in Clipboard
Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373.
Alves K, Plested JS, Galbiati S, Chau G, Cloney-Clark S, Zhu M, Kalkeri R, Patel N, Smith K, Marcheschi A, Pfeiffer S, McFall H, Smith G, Glenn GM, Dubovsky F, Mallory RM; Novavax 2019nCoV-101 Study Group.
Alves K, et al. Among authors: marcheschi a.
N Engl J Med. 2023 Mar 2;388(9):857-859. doi: 10.1056/NEJMc2215509. Epub 2023 Jan 25.
N Engl J Med. 2023.
PMID: 36734884
Free PMC article.
No abstract available.
Item in Clipboard
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.
Mallory RM, Formica N, Pfeiffer S, Wilkinson B, Marcheschi A, Albert G, McFall H, Robinson M, Plested JS, Zhu M, Cloney-Clark S, Zhou B, Chau G, Robertson A, Maciejewski S, Hammond HL, Baracco L, Logue J, Frieman MB, Smith G, Patel N, Glenn GM; Novavax 2019nCoV101 Study Group.
Mallory RM, et al. Among authors: marcheschi a.
Lancet Infect Dis. 2022 Nov;22(11):1565-1576. doi: 10.1016/S1473-3099(22)00420-0. Epub 2022 Aug 10.
Lancet Infect Dis. 2022.
PMID: 35963274
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite